Saphnelo

(anifrolumab-fnia)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

The recommended dosage is 300 mg as an intravenous infusion over a 30‑minute period every 4 weeks. For complete dilution and intravenous administration instructions see Full Prescribing Information.

   

Saphnelo Prescribing Information

Saphnelo Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

Reimbursement help (FRM)

Saphnelo Financial Assistance Options

Copay savings program

View more

Foundation programs

View more

Saphnelo PubMed™ News

    Saphnelo Patient Education

    Patient toolkit